Quarterly report · Q2
2931.TEDINET S100RO90
Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.8bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥44.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥21.6bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | −¥760m | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | −¥1.4bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | −¥639m | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥2.5bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥597m | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥618m | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥595m | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥914m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.7bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥465m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥913m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | −¥462m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥60.8bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥57.3bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥58.6bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥39.1bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥37.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥21.7bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥19.4bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.9bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥16.3bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.0bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥16.2bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥500m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥924m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥351m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥1.2bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥531m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥6.2bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-7.88 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.38 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-23.83 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.18 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.54 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 35.7% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥862m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥901m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥901m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥432m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥20.5bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥20.5bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥724m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥189m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-06-30 | ¥22.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-06-30 | ¥22.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-06-30 | ¥101m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥810m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥63m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥63m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥376m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥20.2bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥20.2bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥122m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥113m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-06-30 | ¥21.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-06-30 | ¥21.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-06-30 | −¥611m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 627
| Item | Context | Value | Unit |
|---|---|---|---|
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsOtherMember | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)株式会社ユーグレナ | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都港区芝5-29-11 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |